Combination treatment improves lung cancer outcomes, finds study

A new study has found that patients with non-small cell lung cancer (NSCLC) treated with a combination of low-dose radiation and immunotherapy had higher progression-free survival compared to patients who received immunotherapy alone two years after treatment.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart